Folotyn for Non-Hodgkin's Lymphoma West Islip NY

The drug Folotyn (pralatrexate) has been approved to treat Peripheral T-cell Lymphoma (PTCL), an often aggressive form of non-Hodgkin's lymphoma, the U.S. Food and Drug Administration said Friday. The drug, given accelerated approval because it treats an unmet medical need, was sanctioned for people whose disease has returned or hasn't responded to other types of chemotherapy, the agency said in a news release.

Local Companies

VINOD GULATI, MD
(631) 789-2020
333 Broadway
Amityville, NY
MARY PUCCIO, MD
(631) 666-6752
24 E Main Street
Bay Shore, NY
NATALYA KRICHMAR, MD
(516) 755-2404
200 Boundary Avenue
Massapequa, NY
Jeffrey Lee Vacirca, MD
631-751-3000
235 North Belle Rd
East Setauket, NY
Mark David Lipshutz, MD
631-666-6752
24 E Main St
Bay Shore, NY
Pamela R Drullinsky
(646) 227-3813
1000 N Village Ave
Rockville Centre, NY
MAGDY SHAABAN, MD
(516) 223-0700
865 Merrick Road
Baldwin, NY
JAGADAMMA NAIR, MD
(516) 572-6131
2201 Hempstead Turnpike
East Meadow, NY
Loriann Attivissimo, MD
516-367-1810
5 Seward Dr
Woodbury, NY
Edward T Samuel, MD
631-751-3000
235 N Belle Mead Rd
East Setauket, NY
Data Provided by:
    

Provided By:

FRIDAY, Sept. 25 (HealthDay News) -- The drug Folotyn (pralatrexate) has been approved to treat Peripheral T-cell Lymphoma (PTCL), an often aggressive form of non-Hodgkin's lymphoma, the U.S. Food and Drug Administration said Friday.

The drug, given accelerated approval because it treats an unmet medical need, was sanctioned for people whose disease has returned or hasn't responded to other types of chemotherapy, the agency said in a news release.

PTCL strikes fewer than 9,500 people each year in the United States, the FDA said. The disease affects a type of white blood cell, called a T-cell, involved in the body's disease-fighting immune system.

Approval of Folotyn was based on clinical data showing it reduced tumor size in 27 percent of 109 people with PTCL who were studied. The most common adverse reactions included sores of the lips, mouth and digestive tract, low white blood cell counts, fever, nausea and fatigue.

Since the drug can harm a fetus, women taking Folotyn should avoid becoming pregnant, the FDA said. Anyone taking the drug should also take folate and vitamin B12 supplements to help reduce irritation of the mucous membranes.

Folotyn is produced by Colorado-based Allos Therapeutics, which is required to conduct additional studies of tumor shrinkage and life expectancy, the agency said.

More information

The FDA has more about this drug.

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com

Related Articles
- Green Tea and Hematologic Malignancies West Islip NY
Read more about Green Tea May Lower the Risk of Hematologic Malignancies.
- Donor Stem-Cell Transplant for Acute Myeloid Leukemia West Islip NY